J9021 Insurance Policy Changes

HCPCS J9021 is officially defined as "Injection, asparaginase, recombinant, (rylaze), 0.1 mg." HCPCS J9021 is referenced in 2 tracked payer policy changes from Highmark and Florida Blue. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9021 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Related

All billing codesJ35909921299213992029921199214

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert